Human microbiome, also known as microbiota, includes microbes such as fungi, bacteria, and virus. These microbes reside in oral mucosa, saliva, gastrointestinal tracts, conjunctiva, or on the surface or in deep layers of the skin. At present, extensive research is being conducted to discover the importance of these micro-organisms in maintaining immune systems and their contribution in digestion of food. Large number of microbes reside in the large intestine, with region of the human body having a distinct community of microbes dwelling. Studies are still in progress to understand factors regulating microbial colonization in the body that are just millimeters apart. The human microbiome project (HMP) was launched in 2008 as a U.S. National Institute of Health. This was initiated to identify and characterize microbes found in the healthy and diseases human body.
The demand within the global market for human microbiome has been rising alongside advancements in
the field of advancements in the field of microscopic research on human health, finds Transparency
The competitors in the global human microbiome market are focusing on creating a stellar framework
for continual growth. It is expected that the market vendors in the global human microbiome market
would aim at continually revamping and re-analyzing their business strategies in order to earn the
benefits of market innovation. Furthermore, the market for human microbiome is also expected to
witness the emergence of new market vendors in the years to come.
The leading market vendors in the global human microbiome market have made ardent efforts to
ensure that their dominance remains unaffected. These vendors have directed huge of money towards
outbound marketing, research and development, and clinical trials.
Request a PDF Sample -
The small and medium-sized vendors are under a negative spot due to the rising competition from the
established. The small vendors in the global human microbiome market may form collective alliances to
sustain in the market. Some of the key vendors in the global market for human microbiome are Seres
Therapeutics, Rebiotix, Inc., uBiome, Inc., Enterome, and Biosciences.
Transparency Market Research (TMR) finds that the global human microbiome market would expand at
a healthy CAGR of 9.80% over the period between 2018 and 2026. Furthermore, the cumulative value of
the global human microbiome is expected to touch US$ 1888.9 Mn by 2026. On the basis of geography,
the market for human microbiome in North America is expected to expand at a stellar pace in the years
to come. This essentially owes to the presence of key research entities in the US and Canada.
Request for Custom Research -
Need for Impro